{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:53:23Z","timestamp":1786136003689,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Metaplastic breast cancer (MBC) is a rare and aggressive form of breast cancer. The effectiveness of chemotherapy followed by radiotherapy (CFRT) for MBC remains controversial. The present study aimed to evaluate the efficacy of CFRT on MBC patients with N0M0. A retrospective study was performed to analyze MBC from the surveillance, epidemiology, and end results database. Breast cancer-specific survival (BCSS) and overall survival (OS) rates were analyzed using the Kaplan\u2013Meier curve. Cox proportional hazard models were used to assess BCSS and OS. CFRT might be a valid therapeutic strategy for MBC with N0M0, especially considered with surgical planning. Of the 4672 MBC patients in the surveillance, epidemiology, and end results registry, our final sample comprised 2260 patients. A total of 602 (26.6%), 292 (12.9%), 638 (28.2%), and 728 (32.2%) patients received non-therapy, only-radiotherapy, only-chemotherapy, and CFRT, respectively. Age, tumor size, tumor grade, surgery, and therapy types were independent indicators for BCSS. The Kaplan\u2013Meier analysis showed that total mastectomy (TM) not breast-conserving surgery (BCS) improved BCSS of MBC receiving CFRT, whereas OS of MBC receving CFRT can not benefit from surgical type. Further exploration illustrated that, for BCSS, only stage T2 and T3 MBC patients underwent BCS and only stage T3 MBC patients underwent TM could benefit from CFRT. However, for OS, all stage MBC patients underwent BCS and only stage T3 MBC patients underwent TM could benefit from CFRT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049401","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:01:21Z","timestamp":1786125681000},"page":"e49401","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A retrospective study of metaplastic breast cancer: Treatment and prognosis through chemotherapy followed by radiotherapy"],"prefix":"10.1097","volume":"105","author":[{"given":"Zankai","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxia","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7773-9191","authenticated-orcid":false,"given":"Jin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260807","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2162-3619-2-31","article-title":"Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies.","volume":"2","author":"Schwartz","year":"2013","journal-title":"Exp Hematol Oncol"},{"key":"R2-20260807","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.clbc.2016.06.002","article-title":"Management and outcomes in metaplastic breast cancer.","volume":"16","author":"Tzanninis","year":"2016","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"R3-20260807","first-page":"89","article-title":"Classification of metaplastic carcinomas of the breast.","volume":"27","author":"Tavassoli","year":"1992","journal-title":"Pathol Annu"},{"key":"R6-20260807","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0046-8177(89)90149-4","article-title":"Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma.","volume":"20","author":"Wargotz","year":"1989","journal-title":"Hum Pathol"},{"key":"R7-20260807","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0046-8177(89)90065-8","article-title":"Metaplastic carcinomas of the breast. II. Spindle cell carcinoma.","volume":"20","author":"Wargotz","year":"1989","journal-title":"Hum Pathol"},{"key":"R8-20260807","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/1097-0142(19891001)64:7<1490::AID-CNCR2820640722>3.0.CO;2-L","article-title":"Metaplastic carcinomas of the breast. III. Carcinosarcoma.","volume":"64","author":"Wargotz","year":"1989","journal-title":"Cancer"},{"key":"R9-20260807","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/1097-0142(19900115)65:2<272::AID-CNCR2820650215>3.0.CO;2-6","article-title":"Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin.","volume":"65","author":"Wargotz","year":"1990","journal-title":"Cancer"},{"key":"R10-20260807","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/0046-8177(90)90151-T","article-title":"Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells.","volume":"21","author":"Wargotz","year":"1990","journal-title":"Hum Pathol"},{"key":"R11-20260807","first-page":"552","article-title":"NCCN guidelines updates: breast cancer.","volume":"17","author":"Telli","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"R12-20260807","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1245\/s10434-006-9124-7","article-title":"Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base.","volume":"14","author":"Pezzi","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R13-20260807","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-0780-8","article-title":"Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer.","volume":"120","author":"Jung","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"R14-20260807","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/jjco\/hyp139","article-title":"Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity.","volume":"40","author":"Lim","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"R15-20260807","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1245\/s10434-014-3890-4","article-title":"Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.","volume":"22","author":"Nelson","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R16-20260807","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10549-011-1359-8","article-title":"The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.","volume":"126","author":"Bae","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R17-20260807","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/annonc\/mdl006","article-title":"Biphasic metaplastic sarcomatoid carcinoma of the breast.","volume":"17","author":"Hennessy","year":"2006","journal-title":"Ann Oncol"},{"key":"R18-20260807","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jclinpath-2011-200586","article-title":"Metaplastic breast cancer: clinicopathological features and its prognosis.","volume":"65","author":"Lee","year":"2012","journal-title":"J Clin Pathol"},{"key":"R19-20260807","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1158\/1078-0432.CCR-17-0108","article-title":"Whole-exome sequencing of metaplastic breast carcinoma indicates monoclonality with associated ductal carcinoma component.","volume":"23","author":"Avigdor","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R20-20260807","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/path.5184","article-title":"Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.","volume":"247","author":"McCart Reed","year":"2019","journal-title":"J Pathol"},{"key":"R21-20260807","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/1078-0432.CCR-16-2857","article-title":"The landscape of somatic genetic alterations in metaplastic breast carcinomas.","volume":"23","author":"Ng","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R22-20260807","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41523-017-0048-0","article-title":"Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast.","volume":"3","author":"Piscuoglio","year":"2017","journal-title":"NPJ Breast Cancer"},{"key":"R23-20260807","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clbc.2017.04.009","article-title":"Metaplastic carcinoma of the breast is more aggressive than triple-negative breast cancer: a study from a single institution and review of literature.","volume":"17","author":"El Zein","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"R24-20260807","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.breast.2021.10.004","article-title":"Presentation and survival by hormonal receptor status in metaplastic breast cancer: a propensity score-matched analysis.","volume":"60","author":"Wang","year":"2021","journal-title":"Breast"},{"key":"R25-20260807","doi-asserted-by":"crossref","first-page":"628939","DOI":"10.3389\/fendo.2021.628939","article-title":"Single hormone receptor-positive metaplastic breast cancer: similar outcome as triple-negative subtype.","volume":"12","author":"Mao","year":"2021","journal-title":"Front Endocrinol"},{"key":"R26-20260807","doi-asserted-by":"crossref","first-page":"101054","DOI":"10.1016\/j.tranon.2021.101054","article-title":"Metaplastic breast cancer: treatment and prognosis by molecular subtype.","volume":"14","author":"Hu","year":"2021","journal-title":"Transl Oncol"},{"key":"R27-20260807","first-page":"11689","article-title":"Triple-negative metaplastic breast cancer: treatment and prognosis by type of surgery.","volume":"13","author":"Hu","year":"2021","journal-title":"Am J Transl Res"},{"key":"R28-20260807","first-page":"e10339","article-title":"Patterns of care and survival of metastatic metaplastic breast cancer patients.","volume":"12","author":"Youssef","year":"2020","journal-title":"Cureus"},{"key":"R29-20260807","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1245\/s10434-010-1198-6","article-title":"Metaplastic breast cancer: to radiate or not to radiate?","volume":"18","author":"Tseng","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R30-20260807","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1245\/s10434-018-6533-3","article-title":"Metaplastic breast cancer treatment and outcomes in 2500 patients: a retrospective analysis of a national oncology database.","volume":"25","author":"Ong","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R31-20260807","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1008329910362","article-title":"Metaplastic breast cancer: prognosis and response to systemic therapy.","volume":"10","author":"Rayson","year":"1999","journal-title":"Ann Oncol"},{"key":"R32-20260807","first-page":"ED05","article-title":"Adenosquamous variant of metaplastic carcinoma of breast - an unusual histological variant.","volume":"9","author":"Swathy","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"R33-20260807","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41523-017-0011-0","article-title":"Dramatic response of metaplastic breast cancer to chemo-immunotherapy.","volume":"3","author":"Adams","year":"2017","journal-title":"NPJ Breast Cancer"},{"key":"R34-20260807","first-page":"e454","article-title":"A case of metaplastic breast cancer with prolonged response to single agent liposomal doxorubicin.","volume":"8","author":"Hamad","year":"2016","journal-title":"Cureus"},{"key":"R35-20260807","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1634\/theoncologist.2017-0398","article-title":"Early and locally advanced metaplastic breast cancer: presentation and survival by receptor status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.","volume":"23","author":"Schroeder","year":"2018","journal-title":"Oncologist"},{"key":"R36-20260807","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.breast.2019.10.003","article-title":"Comparison of outcomes between metaplastic and triple-negative breast cancer patients.","volume":"49","author":"Polamraju","year":"2020","journal-title":"Breast"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:02:01Z","timestamp":1786132921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":34,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049401","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"2024-04-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}